Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Inovio Pharmaceuticals Inc INO

Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.


NDAQ:INO - Post by User

Bullboard Posts
Post by MiamiGenton Aug 17, 2013 11:17pm
403 Views
Post# 21678941

INO continues to plummet- down 55% in nine days

INO continues to plummet- down 55% in nine days INO continues to plummet- down to 1.36 on Friday.
That's a 55% decline from 3.03 nine trading days ago.
That's how pump & dumps go.
Disre*****ble play surrounds this stock- misleading e-mail promotions written in poor English and an avalanche of deceptive message board posts.

Inexperienced investors & traders: you will likely lose money on INO. Many who fell for this pump & dump have already lost a lot. Even some of the sharpies.
I suggest finding an untainted stock to invest in, preferably a big board stock (fully reporting).
You'll have good self esteem knowing your win came from fair play and possibly some skill- not from innocent investors who were snookered.

Good trading and investing to you!

MG
In Memory of Stoney

Bullboard Posts